Skip to main content

Atopic Dermatitis

  • Chapter
  • First Online:
Absolute Allergy and Immunology Board Review
  • 570 Accesses

Abstract

Atopic dermatitis (AD) is the most common chronic and relapsing, pruritic, inflammatory skin disease that affects both children and adults with a prevalence of up to 18% and 7%, respectively. The atopic dermatitis pathogenesis is multifactorial: epidermal barrier dysfunction, immunological abnormalities as antimicrobial peptides deficiency, host genetics as null mutations in the gene encoding the epidermal structural protein filaggrin (FLG) and missense variants in genes encoding the TH2 signature cytokine IL-13 and IL-6R, altered skin microbiota, and environmental factors. AD patients have an increased risk of bacterial, viral, and fungal infections, such as S. aureus, Herpes simplex, Molluscum, and Malassezia. Some endotypes are associated with a higher risk for the atopic march: early onset AD, those with polysensitization, with an atopic parent, with a persistent or severe endotype, and those with a filaggrin mutation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Robert B, Pavel A, Diaz A, et al. Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial. J Allergy Clin Immunol. 2019;144(1274):89.

    Google Scholar 

  2. Boguniewicz M, Leung DYM. Atopic dermatitis. Middleton’s allergy: principles and practice. Immunol Rev. 2020;33:530–52.

    Google Scholar 

  3. Erickson S, Ver Heul A, Kim BS. New and emerging treatments for inflammatory itch. Ann Allergy Asthma Immunol. 2021;126:13–20.

    Article  CAS  PubMed  Google Scholar 

  4. Kumar R, Seibold MA, Burchard E. Atopic dermatitis, race and genetics. J Allergy Clin Immunol. 2020;145:108–10.

    Article  PubMed  Google Scholar 

  5. Oetjen LK, Mack MR, Feng J, et al. Sensory neurons co-opt classical immune signaling pathways to chronic itch. Cell. 2017;171(1):217–228e13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Raap U, Wichmann K, Bruder M, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol. 2017;122(2):421–3.

    Article  Google Scholar 

  7. Ständer S. Atopic dermatitis. N Engl J Med. 2021;384(12):1136–43.

    Article  PubMed  Google Scholar 

  8. Wang V, et al. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:3–12.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Malinow, I. (2022). Atopic Dermatitis. In: Mahmoudi, M. (eds) Absolute Allergy and Immunology Board Review. Springer, Cham. https://doi.org/10.1007/978-3-031-12867-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-12867-7_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-12866-0

  • Online ISBN: 978-3-031-12867-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics